Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells
Creators
- 1. Department of Immunology, Microbiology and Biochemistry, Wayne State University, Detroit, MI (United States)
- 2. Department of Environmental Medicine, University of Rochester, Rochester, NY (United States)
- 3. Center for Urban Responses to Environmental Stressors (CURES), Wayne State University, Detroit, MI (United States)
Description
Mercury (Hg) has been implicated as a factor contributing to autoimmune disease in animal models and humans. However the mechanism by which this occurs has remained elusive. Since the discovery of B cells it has been appreciated by immunologists that during the normal course of B cell development, some immature B cells must be generated that produce immunoglobulin reactive to self-antigens (auto-antibodies). However in the course of normal development, the vast majority of immature auto-reactive B cells are prevented from maturing by processes collectively known as tolerance. Autoimmune disease arises when these mechanisms of tolerance are disrupted. In the B cell compartment, it is firmly established that tolerance depends in part upon negative selection of self-reactive immature (transitional type 1) B cells. In these cells negative selection depends upon signals generated by the B Cell Receptor (BCR), in the sense that those T1 B cells who's BCRs most strongly bind to, and so generate the strongest signals to self-antigens are neutralized. In this report we have utilized multicolor phosphoflow cytometry to show that in immature T1 B cells Hg attenuates signal generation by the BCR through mechanisms that may involve Lyn, a key tyrosine kinase in the BCR signal transduction pathway. We suggest that exposure to low, environmentally relevant levels of Hg, disrupts tolerance by interfering with BCR signaling in immature B cells, potentially leading to the appearance of mature auto-reactive B cells which have the ability to contribute to auto-immune disease. - Highlights: • Hg2+ interferes with BCR-mediated activation of ERK in immature T1 B cells. • Hg2+ acts upstream of ERK. • BCR mediated activation of Syk and the CD79a ITAM are attenuated in immature T1 B cells by Hg2+. • The mechanism whereby which Hg2+ affects Syk and CD7a activation involves the tyrosine phosphokinase Lyn.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.taap.2017.06.022Additional details
Identifiers
- DOI
- 10.1016/j.taap.2017.06.022;
- PII
- S0041-008X(17)30278-8;
Publishing Information
- Journal Title
- Toxicology and Applied Pharmacology
- Journal Volume
- 330
- Journal Page Range
- p. 22-29
- ISSN
- 0041-008X
- CODEN
- TXAPA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49073717
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- DISEASES; MERCURY; RECEPTORS; SIGNALS; TOLERANCE
- Descriptors DEC
- ELEMENTS; MEMBRANE PROTEINS; METALS; ORGANIC COMPOUNDS; PROTEINS
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.